Published in Microbiol Esp on September 03, 1969
Role of capsule and O antigen in resistance of Klebsiella pneumoniae to serum bactericidal activity. Infect Immun (1986) 2.27
Lipopolysaccharide-specific bacteriophage for Klebsiella pneumoniae C3. J Bacteriol (1985) 1.24
A new episomic element controlling fermentative metabolism and excretion of amino acids by Citrobacter intermedium C3. J Bacteriol (1974) 0.86
An association between viral genes and human oncogenic alterations: the adenovirus E1A induces the Ewing tumor fusion transcript EWS-FLI1. Nat Med (1999) 3.27
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect (2014) 2.47
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect (2014) 1.70
[Study of 164 episodes of infectious endocarditis in drug addicts: comparison of HIV positive and negative patients]. Rev Clin Esp (1994) 1.38
Activity of E-3846, a new fluoroquinolone, in vitro and in experimental cystitis and pyelonephritis in rats. Antimicrob Agents Chemother (1988) 1.37
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. Clin Microbiol Infect (2014) 1.36
Effect of hypoxic conditions on in vitro susceptibility testing of amphotericin B, itraconazole and micafungin against Aspergillus and Candida. J Antimicrob Chemother (2004) 1.16
Retracted Nationwide sentinel surveillance of bloodstream Candida infections in 40 tertiary care hospitals in Spain. J Clin Microbiol (2010) 1.16
Workload due to Aspergillus fumigatus and significance of the organism in the microbiology laboratory of a general hospital. J Clin Microbiol (2005) 1.11
In vitro antifungal activity of isavuconazole against 345 mucorales isolates collected at study centers in eight countries. J Chemother (2009) 1.05
In vitro and in vivo antibacterial activities of E-4497, a new 3-amine-3-methyl-azetidinyl tricyclic fluoroquinolone. Antimicrob Agents Chemother (1991) 1.04
Glucose-6-phosphate dehydrogenase alloenzymes and their relationship to pigmentation in Serratia marcescens. Appl Environ Microbiol (1987) 0.98
Candida tropicalis fungaemia: incidence, risk factors and mortality in a general hospital. Clin Microbiol Infect (2010) 0.97
Comparative in vitro and in vivo activities of six new monofluoroquinolone and difluoroquinolone 3-carboxylic acids with a 7-azetidin ring substituent. Antimicrob Agents Chemother (1990) 0.96
[Colony analysis of the production of glutamic acid by Citrobacter intermedium C3]. Microbiol Esp (1971) 0.94
Pseudoalteromonas antarctica sp. nov., isolated from an Antarctic coastal environment. Int J Syst Bacteriol (1997) 0.93
Brown pigmentation in Serratia marcescens cultures associated with tyrosine metabolism. Can J Microbiol (1989) 0.91
Antibacterial activity and pharmacokinetics of four new 7-azetidinyl fluoroquinolones. Antimicrob Agents Chemother (1996) 0.90
A new episomic element controlling fermentative metabolism and excretion of amino acids by Citrobacter intermedium C3. J Bacteriol (1974) 0.86
Outbreak of invasive aspergillosis after major heart surgery caused by spores in the air of the intensive care unit. Clin Infect Dis (2012) 0.83
Production and Rheological Properties of the Extracellular Polysaccharide Synthesized by Pseudomonas sp. Strain EPS-5028. Appl Environ Microbiol (1986) 0.83
[Production of alanine by fermentation with Citrobacter intermedium C3]. Rev Esp Fisiol (1969) 0.82
Workload and clinical significance of the isolation of zygomycetes in a tertiary general hospital. Med Mycol (2008) 0.82
Polyphasic taxonomy of a novel yeast isolated from antarctic environment; description of Cryptococcus victoriae sp. nov. Syst Appl Microbiol (1999) 0.81
[Effect of glucose concentration on the biosynthesis of prodigiosin by serratia marcescens (author's transl)]. Rev Esp Fisiol (1978) 0.80
7,10-Dihydroxy-8(E)-octadecenoic acid produced by Pseudomonas 42A2: evaluation of different cultural parameters of the fermentation. World J Microbiol Biotechnol (1994) 0.80
Isolation from urine of two Serratia marcescens strains excreting a diffusible yellow pigment. J Gen Microbiol (1987) 0.79
Macrophage activation syndrome as the initial manifestation of systemic onset juvenile idiopathic arthritis. Clin Exp Rheumatol (2002) 0.79
Secondary metabolites from a Streptomyces strain isolated from Livingston Island, Antarctica. Z Naturforsch C (2001) 0.79
Bioconcentration of pesticides in zebrafish eleutheroembryos (Danio rerio). Sci Total Environ (2012) 0.79
Zebrafish larvae as a model for the evaluation of inorganic arsenic and tributyltin bioconcentration. Water Res (2011) 0.78
Characterization of clinical strains of Aspergillus terreus complex: molecular identification and antifungal susceptibility to azoles and amphotericin B. Clin Microbiol Infect (2011) 0.78
Nosocomial invasive aspergillosis in a heart transplant patient acquired during a break in the HEPA air filtration system. Transpl Infect Dis (2004) 0.77
R-bodies in Pseudomonas aeruginosa strain 44T1. Antonie Van Leeuwenhoek (1991) 0.77
Morphological characterization of the Serratia marcescens bacteriophage SLP. J Basic Microbiol (1985) 0.77
Seronegative oligoarthritis in the course of refractory anaemia with excess blasts. Rheumatology (Oxford) (1999) 0.77
Rapid determination of polycyclic aromatic hydrocarbons (PAHs) in zebrafish eleutheroembryos as a model for the evaluation of PAH bioconcentration. Talanta (2012) 0.76
Study of 42 cases of infective endocarditis in the HAART era in Spain. Clin Microbiol Infect (2003) 0.75
Protective effect caused by the exopolymer excreted by Pseudoalteromonas antarctica NF(3) on liposomes against the action of octyl glucoside. Int J Pharm (2000) 0.75
Assembly properties and applications of a new exopolymeric compound excreted by Pseudoalteromonas antarctica NF3. J Biomater Sci Polym Ed (2001) 0.75
Antibacterial activities and pharmacokinetics of E-4767 and E-5065, two new 8-chlorofluoroquinolones with a 7-azetidin ring substituent. Antimicrob Agents Chemother (2001) 0.75
[Streptococcus pneumoniae endocarditis]. Med Clin (Barc) (1994) 0.75
Induction of Yellow Pigmentation in Serratia marcescens. Appl Environ Microbiol (1988) 0.75
Dietary chromic oxide does not affect the utilization of organic compounds but can alter the utilization of mineral salts in gilthead sea bream Sparus aurata. J Nutr (1999) 0.75
Bioaccumulation and transformation of methylmercury and selenite using zebrafish (Danio Rerio) larvae as a model. Talanta (2011) 0.75
[Myocardial abscess without concomitant valve lesion and parenteral drug addiction]. Rev Clin Esp (1992) 0.75
[Cell-wall-deficient forms in Citrobacter intermedius C]. Microbiol Esp (1978) 0.75
Characterization of B278, a phage different from Mu that also produces auxotrophic mutations in Escherichia coli K12. J Gen Microbiol (1988) 0.75
Ability of the exopolymer excreted by Pseudoalteromonas antarctica NF3, to coat liposomes and to protect these structures against octyl glucoside. J Biomater Sci Polym Ed (1999) 0.75
[The evaluation of heterosexual transmission of the human immunodeficiency virus by nucleic acid amplification technics]. Med Clin (Barc) (1990) 0.75
A system for finger tremor quantification in patients with Parkinson's disease. Conf Proc IEEE Eng Med Biol Soc (2017) 0.75
[Renal function in hypoxemia]. Med Clin (Barc) (1986) 0.75
Selective effects of E1B-defective adenoviruses and adenovirus E1A mutants in deficient mouse primary embryonic fibroblasts. Int J Oncol (2001) 0.75
[Adult Kawasaki disease]. Rev Clin Esp (2010) 0.75
[Bacteriologic study of new phenyl and nitrofuran derivatives. I. Initial prospect and influence of the bromovinylene group]. Microbiol Esp (1966) 0.75
Is catheter-related candidemia a polyclonal infection? Med Mycol (2014) 0.75
[Genetic analysis of the equilibrium between glutamine segregator and nonsegregator elements in C. intermedium C 3 populations]. Microbiol Esp (1973) 0.75
Miniaturized extraction methods of triclosan from aqueous and fish roe samples. Bioconcentration studies in zebrafish larvae (Danio rerio). Anal Bioanal Chem (2012) 0.75
[Candidemia and invasive candidiasis approach in critically ill patients: role of the echinocandins]. Rev Esp Quimioter (2017) 0.75
[Influence of the inoculum on the growth of Citrobacter intermedium C3 in a discontinued culture]. Microbiol Esp (1970) 0.75
Effect of gramicidin A and valinomycin on prodigiosin production by non-proliferating Serratia marcescens. J Antibiot (Tokyo) (1987) 0.75
Enhancement by polymyxin B of proline-induced prodigiosin biosynthesis in non-proliferating cells of Serratia marcescens. Microbiologica (1983) 0.75
[Infectious endocarditis caused by Escherichi coli]. Enferm Infecc Microbiol Clin (1996) 0.75
[Taxonomic identification of Pseudomonas azotogensis]. Microbiol Esp (1970) 0.75
[Zygomycetes and zygomycosis in the new era of antifungal therapies]. Rev Esp Quimioter (2007) 0.75
[Growth inhibition of C. intermedium C3 and other microorganisms by soluble factors excreted into the culture media]. Microbiol Esp (1978) 0.75
[Bacteriologic study of new phenyl and nitrofuran derivatives. II. Bacterial sensitivity and susceptibility of urinary strains]. Microbiol Esp (1966) 0.75
The transfer of a factor which determines glutamate secretion from Citrobacter intermedium C-3 to Paracolobactrum intermedium. J Gen Microbiol (1969) 0.75
[Stenosis of the right ventricle outlet through anomalous muscular bands]. Rev Esp Cardiol (1977) 0.75
[Severe pulmonary hypertensión treated with low dose carvedilol in a patient infected with the human immunodeficiency virus]. Enferm Infecc Microbiol Clin (2001) 0.75
Partitioning of SDS in liposomes coated by the exopolymer excreted by Pseudoalteromonas antarctica NF3 as a measure of vesicle protection against this surfactant. J Biomater Sci Polym Ed (2001) 0.75